Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer

BACKGROUND. Liquid biopsies have demonstrated that the constitutively active androgen receptor splice variant-7 (AR-V7) associates with reduced response and overall survival from endocrine therapies in castration-resistant prostate cancer (CRPC). However, these studies provide little information per...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharp, Adam, Coleman, Ilsa, Yuan, Wei, Sprenger, Cynthia, Dolling, David, Rodrigues, Daniel Nava, Russo, Joshua W., Figueiredo, Ines, Bertan, Claudia, Seed, George, Riisnaes, Ruth, Uo, Takuma, Neeb, Antje, Welti, Jonathan, Morrissey, Colm, Carreira, Suzanne, Luo, Jun, Nelson, Peter S., Balk, Steven P., True, Lawrence D., de Bono, Johann S., Plymate, Stephen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2018
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307949/
https://www.ncbi.nlm.nih.gov/pubmed/30334814
http://dx.doi.org/10.1172/JCI122819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307949/
https://www.ncbi.nlm.nih.gov/pubmed/30334814
http://dx.doi.org/10.1172/JCI122819

Ejemplares similares